MLchartDataset catalogue

immunomodulatory agent CC-11006

Term · Oncology and biomedicine · MLC-T-ONC-014389

A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.

Table 1. Record
IdentifierMLC-T-ONC-014389
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-014389",
  "term": "immunomodulatory agent CC-11006",
  "field": "Oncology and biomedicine",
  "definition": "A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/immunomodulatory-agent-cc-11006/"
}

Record 9,111 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.